We are live on !
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.5B
Turnover
9.58%
1-Year Est. Return
31.38%
This Quarter Est. Return
+1.36%
1 Year Est. Return
+31.38%
3 Year Est. Return
+126.98%
5 Year Est. Return
+155.3%
10 Year Est. Return
+569.87%
AUM
$69.5B
AUM Growth
+$369M
(+0.53%)
Cap. Flow
+$545M
Cap. Flow % of AUM
Cap. Flow %
0.78%
Top 10 Holdings %
Top 10 Hldgs %
48.49%
Holding
1,973
New
60
Increased
600
Reduced
1,180
Closed
129
Avg Time Held
6.7
years
Top 10 Avg Time Held
5.8
years
Top 20 Avg Time Held
5.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$574M |
| 2 |
NVIDIA
NVDA
|
+$259M |
| 3 |
Broadcom
AVGO
|
+$97.8M |
| 4 |
Micron Technology
MU
|
+$83.1M |
| 5 |
Albemarle
ALB
|
+$73.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares GENIUS Money Market ETF
IQMM
|
+$492M |
| 2 |
General Dynamics
GD
|
+$220M |
| 3 |
Gilead Sciences
GILD
|
+$194M |
| 4 |
Genuine Parts
GPC
|
+$189M |
| 5 |
Electronic Arts
EA
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.38% |
| 2 | Miscellaneous | 26.4% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Staples | 6.28% |
| 5 | Consumer Discretionary | 6.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
801
Travere Therapeutics
TVTX
$4.96B
| $853K | ﹤0.01% |
14,493
-265
| -2% | -$16.2K |
2020 Q2
25 quarters
|
|
802
Novanta
NOVT
$5.52B
| $852K | ﹤0.01% |
5,993
-166
| -3% | -$24.6K |
2020 Q2
25 quarters
|
|
803
Essent Group
ESNT
$5.79B
| $849K | ﹤0.01% |
14,657
-938
| -6% | -$62.6K |
2016 Q4
39 quarters
|
|
804
BioMarin Pharmaceuticals
BMRN
$11.1B
| $844K | ﹤0.01% |
14,068
+108
| +0.8% | +$6.8K |
2013 Q2
53 quarters
|
|
805
Sensient Technologies
SXT
$5.18B
| $843K | ﹤0.01% |
6,450
-230
| -3% | -$29.2K |
2013 Q2
53 quarters
|
|
806
Lumen Technologies, Inc. Common Stock
LUMN
$4.45B
| $841K | ﹤0.01% |
150,188
+4,770
| +3% | +$30.4K |
2013 Q2
53 quarters
|
|
807
Murphy Oil
MUR
$4.95B
| $835K | ﹤0.01% |
22,544
-934
| -4% | -$33.9K |
2020 Q4
23 quarters
|
|
808
CRISPR Therapeutics
CRSP
$4.85B
| $832K | ﹤0.01% |
15,043
-732
| -5% | -$39.5K |
2025 Q2
5 quarters
|
|
809
Selective Insurance
SIGI
$5.99B
| $829K | ﹤0.01% |
9,921
-425
| -4% | -$39.5K |
2013 Q2
53 quarters
|
|
810
LPL Financial
LPLA
$23.8B
| $827K | ﹤0.01% |
2,703
+591
| +28% | +$201K |
2026 Q2
1 quarter
|
|
811
Sabra Healthcare REIT
SBRA
$5.62B
| $824K | ﹤0.01% |
41,787
-1,616
| -4% | -$33.2K |
2017 Q3
36 quarters
|
|
812
Semtech
SMTC
$10.9B
| $814K | ﹤0.01% |
4,566
-300
| -6% | -$42.5K |
2013 Q2
53 quarters
|
|
813
Compass
COMP
$8.27B
| $814K | ﹤0.01% |
91,667
-2,503
| -3% | -$28.4K |
2022 Q2
17 quarters
|
|
814
Kite Realty
KRG
$5.07B
| $811K | ﹤0.01% |
33,252
-1,858
| -5% | -$50.2K |
2020 Q2
25 quarters
|
|
815
CNO Financial Group
CNO
$5.22B
| $810K | ﹤0.01% |
15,308
-673
| -4% | -$36.4K |
2023 Q1
14 quarters
|
|
816
Main Street Capital
MAIN
$5.36B
| $806K | ﹤0.01% |
14,634
-739
| -5% | -$41.3K |
2023 Q1
14 quarters
|
|
817
ImmunityBio
IBRX
$7.54B
| $805K | ﹤0.01% |
85,284
+320
| +0.4% | +$2.56K |
2020 Q4
23 quarters
|
|
818
Haemonetics
HAE
$5.38B
| $792K | ﹤0.01% |
7,523
-488
| -6% | -$45.4K |
2013 Q2
53 quarters
|
|
819
Antero Midstream
AM
$9.23B
| $790K | ﹤0.01% |
39,168
-4,636
| -11% | -$102K |
2019 Q3
28 quarters
|
|
820
Tenet Healthcare
THC
$23B
| $782K | ﹤0.01% |
3,060
-338
| -10% | -$83.2K |
2017 Q2
37 quarters
|
|
821
Brookfield Infrastructure Partners
BIP
$18.3B
| $781K | ﹤0.01% |
21,974
-3,388
| -13% | -$129K |
2023 Q1
14 quarters
|
|
822
TD Synnex
SNX
$18.2B
| $781K | ﹤0.01% |
3,039
+90
| +3% | +$23K |
2013 Q2
53 quarters
|
|
823
Essential Properties Realty Trust
EPRT
$6.23B
| $780K | ﹤0.01% |
30,214
-1,213
| -4% | -$36.6K |
2023 Q1
14 quarters
|
|
824
DELISTED
Atkore
ATKR
| $779K | ﹤0.01% |
8,223
+3,737
| +83% | +$324K |
2020 Q4
23 quarters
|
|
825
D-Wave Quantum Inc
QBTS
$4.35B
| $778K | ﹤0.01% |
46,924
-1,989
| -4% | -$36.8K |
2024 Q3
8 quarters
|
|
Similar funds
ProShare Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, ProShare Advisors held 1,973 positions worth $69.5B, up 0.53% from $69.2B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
ProShare Advisors's Q3 2026 filing shows 60 new, 600 increased, 1,180 reduced and 129 closed positions. Its largest new stake was SpaceX: 4,144,774 shares worth $625M. The largest sale was ProShares GENIUS Money Market ETF, an estimated $492M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Miscellaneous and Industrials.
- ProShare Advisors's largest Q3 2026 buy was SpaceX: 4,144,774 shares worth $625M.
- ProShare Advisors added most to NVIDIA in Q3 2026, an estimated $259M increase.
- ProShare Advisors's biggest Q3 2026 reduction was ProShares GENIUS Money Market ETF, cutting an estimated $492M.
- ProShare Advisors fully exited Electronic Arts in Q3 2026, selling an estimated $55.7M.
- ProShare Advisors's ten largest holdings make up 48% of its $69.5B portfolio in Q3 2026.
- ProShare Advisors opened 60 new positions and closed 129 in Q3 2026.
- ProShare Advisors's portfolio value rose 0.53% quarter-over-quarter to $69.5B.
Based on ProShare Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.